Orange Book product · Generic (ANDA)
FORMOTEROL FUMARATE
FORMOTEROL FUMARATE
At a glance
Dec 13, 2022
Approved
Generic (ANDA)
Application
AN
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 13, 2022
3 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
FORMOTEROL FUMARATE
Strength
0.02MG/2ML
Dosage form
SOLUTION
Route
INHALATION
TE code
AN
Application
ANDA 215621
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of FORMOTEROL FUMARATE
- 2007PERFOROMISTBrand (NDA)
NDA 022007 · VIATRIS SPECIALTY
- 2006FORADIL CERTIHALERBrand (NDA)
NDA 021592 · NOVARTIS
- 2001FORADILBrand (NDA)
NDA 020831 · NOVARTIS
- 2025FORMOTEROL FUMARATEGeneric (ANDA)
ANDA 218308 · DEVA HOLDING AS
- 2025FORMOTEROL FUMARATEGeneric (ANDA)
ANDA 215907 · DR REDDYS
- 2024FORMOTEROL FUMARATEGeneric (ANDA)
ANDA 216426 · LEXENPHARM
- 2024FORMOTEROL FUMARATEGeneric (ANDA)
ANDA 218304 · MICRO LABS
- 2023FORMOTEROL FUMARATEGeneric (ANDA)
ANDA 215883 · MANKIND PHARMA
- 2022FORMOTEROL FUMARATEGeneric (ANDA)
ANDA 216486 · RITEDOSE CORP
- 2022FORMOTEROL FUMARATEGeneric (ANDA)
ANDA 215053 · LUPIN
- 2021FORMOTEROL FUMARATEGeneric (ANDA)
ANDA 215078 · ALEMBIC
- 2021FORMOTEROL FUMARATEGeneric (ANDA)
ANDA 091141 · TEVA PHARMS USA INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
